A CLINICAL TRIAL OF HETEROLOGOUS BOOSTER IMMUNIZATION WITH RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) FOR INHALATION AFTER PRIMARY SERIES OF INACTIVATED COVID-19 VACCINE

　　Project No.: Protocol No.: JSVCT137

　　download:Protocol - V1.2_EN_Clean-20230331.pdf